[go: up one dir, main page]

DE69517105D1 - In vitro transposition von artifiziellen transposons mit stumpfen enden - Google Patents

In vitro transposition von artifiziellen transposons mit stumpfen enden

Info

Publication number
DE69517105D1
DE69517105D1 DE69517105T DE69517105T DE69517105D1 DE 69517105 D1 DE69517105 D1 DE 69517105D1 DE 69517105 T DE69517105 T DE 69517105T DE 69517105 T DE69517105 T DE 69517105T DE 69517105 D1 DE69517105 D1 DE 69517105D1
Authority
DE
Germany
Prior art keywords
vitro transposition
blunted ends
artificial transposons
transposons
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69517105T
Other languages
English (en)
Other versions
DE69517105T2 (de
Inventor
Scott E Devine
Jef D Boeke
Lelita T Braiterman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of DE69517105D1 publication Critical patent/DE69517105D1/de
Application granted granted Critical
Publication of DE69517105T2 publication Critical patent/DE69517105T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE69517105T 1994-03-02 1995-03-02 In vitro transposition von artifiziellen transposons mit stumpfen enden Expired - Fee Related DE69517105T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/204,675 US5677170A (en) 1994-03-02 1994-03-02 In vitro transposition of artificial transposons
PCT/US1995/002520 WO1995023875A1 (en) 1994-03-02 1995-03-02 In vitro transposition of artificial transposons

Publications (2)

Publication Number Publication Date
DE69517105D1 true DE69517105D1 (de) 2000-06-29
DE69517105T2 DE69517105T2 (de) 2000-11-16

Family

ID=22758948

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69517105T Expired - Fee Related DE69517105T2 (de) 1994-03-02 1995-03-02 In vitro transposition von artifiziellen transposons mit stumpfen enden

Country Status (7)

Country Link
US (4) US5677170A (de)
EP (1) EP0698124B1 (de)
JP (1) JP3832851B2 (de)
AU (1) AU682588B2 (de)
CA (1) CA2161767A1 (de)
DE (1) DE69517105T2 (de)
WO (1) WO1995023875A1 (de)

Families Citing this family (184)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677170A (en) * 1994-03-02 1997-10-14 The Johns Hopkins University In vitro transposition of artificial transposons
US5811270A (en) * 1994-05-20 1998-09-22 Grandgenett; Duane P. In vitro method for concerted integration of donor DNA molecules using retroviral integrase proteins
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
EP2322614A1 (de) 1995-06-07 2011-05-18 Life Technologies Corporation Rekombinatorische Klonierung unter Verwendung genmanipulierter Rekombinationsorte
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
JP3910248B2 (ja) * 1997-02-14 2007-04-25 オリエンタル酵母工業株式会社 トランスポゼースを用いるｉｎ ｖｉｔｒｏ反応によるＤＮＡ入れ子型欠失の作製方法
ATE374821T1 (de) 1997-02-20 2007-10-15 Univ Johns Hopkins Med Mutationen in atp-abhängigen transpositionsproteinen die die zielortspezifität reduzieren
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
ATE466948T1 (de) 1997-03-11 2010-05-15 Univ Minnesota Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle
AU7729498A (en) 1997-06-13 1998-12-30 President And Fellows Of Harvard College Methods and uses for transposon-based gene targeting
US6548736B1 (en) * 1997-06-13 2003-04-15 President And Fellows Of Harvard College 7B2 knockout transgenic animals as models of endocrine disease
FI103809B1 (fi) * 1997-07-14 1999-09-30 Finnzymes Oy In vitro -menetelmä templaattien tuottamiseksi DNA-sekventointia varten
US6740503B1 (en) 1997-09-26 2004-05-25 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
US6897066B1 (en) 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
US7393632B2 (en) 1999-12-10 2008-07-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US7351578B2 (en) * 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
CN101125873A (zh) * 1997-10-24 2008-02-20 茵维特罗根公司 利用具重组位点的核酸进行重组克隆
NZ504214A (en) * 1997-10-24 2003-06-30 Invitrogen Corp Recombination cloning using nucleic acids having recombination sites
ES2306485T3 (es) * 1997-11-25 2008-11-01 Oryzon Genomics, S.A. Procedimiento de cribado en paralelo de mutantes de insecion y un dispositivo para llevar a cabo dicho procedimiento.
WO1999050402A1 (en) * 1998-03-27 1999-10-07 President And Fellows Of Harvard College Systematic identification of essential genes by in vitro transposon mutagenesis
US6291245B1 (en) * 1998-07-15 2001-09-18 Roche Diagnostics Gmbh Host-vector system
US7160682B2 (en) * 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
EP1159402A4 (de) * 1999-03-02 2003-01-29 Invitrogen Corp ZELLEN, WELCHE RESISTENT GEGENüBER TOXISCHEN GENEN SIND UND DEREN ANWENDUNGEN
EP2336148A1 (de) 1999-03-02 2011-06-22 Life Technologies Corporation Zusammensetzungen und Verfahren zur Verwendung beim Rekombinationsklonen von Nukleinsäuren
US6299850B1 (en) 1999-03-16 2001-10-09 The United States Of America As Represented By The Department Of Energy Carbon activation process for increased surface accessibility in electrochemical capacitors
US6562624B2 (en) 1999-03-17 2003-05-13 Paradigm Genetics, Inc. Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
US7244560B2 (en) * 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6991900B2 (en) 2000-06-28 2006-01-31 California Institute Of Technology Methods for identifying an essential gene in a prokaryotic microorganism
US6852510B2 (en) * 2000-07-03 2005-02-08 Gala Design Inc Host cells containing multiple integrating vectors
US20030224415A1 (en) * 2001-06-29 2003-12-04 Gala Design, Inc. Selection free growth of host cells containing multiple integrating vectors
EP1297168A2 (de) * 2000-07-03 2003-04-02 Gala Design, Inc. Expressionsvektoren
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
EP1390394A4 (de) * 2001-04-19 2004-05-26 Invitrogen Corp Zusammensetzungen und verfahren zur rekombinationsklonierung von nukleinsäuremolekülen
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
AU2003231048A1 (en) * 2002-04-22 2003-11-03 Regents Of The University Of Minnesota Transposon system and methods of use
EP1543128A4 (de) * 2002-07-18 2008-02-20 Invitrogen Corp Virusvektoren mit rekombinationsstellen
EP1386966A1 (de) * 2002-07-24 2004-02-04 Libragen Verfahren zur Expresssion von aus Umweltproben stammender DNA in Wirtszellen
FI20030561A0 (fi) * 2003-04-14 2003-04-14 Finnzymes Oy Menetelmä nukleiinihappojen siirtämiseksi eukaryoottigenomeihin
US20050095615A1 (en) * 2003-06-26 2005-05-05 Welch Peter J. Methods and compositions for detecting promoter activity and expressing fusion proteins
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
WO2005100585A2 (en) * 2004-03-30 2005-10-27 Epicentre Methods for obtaining directionally truncated polypeptides
BRPI0510475B8 (pt) 2004-05-26 2021-05-25 Bayer Pharma AG adenovírus quimérico recombinante, uso do mesmo no tratamento de câncer e métodos de inibição de crescimento de uma célula de câncer, de fornecimento de uma proteína terapêutica a uma célula e para o isolamento do adenovírus
US20060026699A1 (en) * 2004-06-04 2006-02-02 Largaespada David A Methods and compositions for identification of genomic sequences
US20090208924A1 (en) * 2004-12-01 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Generation of Replication Competent Viruses for Therapeutic Use
GB0501189D0 (en) * 2005-01-20 2005-03-02 Univ Cardiff Polypeptide mutagenesis method
WO2008066658A2 (en) * 2006-11-03 2008-06-05 The Trustees Of Princeton University Engineered cellular pathways for programmed autoregulation of differentiation
US8383345B2 (en) 2008-09-12 2013-02-26 University Of Washington Sequence tag directed subassembly of short sequencing reads into long sequencing reads
DK3272879T3 (da) 2008-10-24 2019-08-26 Epicentre Tech Corporation Transposonendesammensætninger og fremgangsmåder til modificering af nukleinsyrer
US9080211B2 (en) 2008-10-24 2015-07-14 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
PL2556171T3 (pl) 2010-04-05 2016-04-29 Prognosys Biosciences Inc Oznaczenia biologiczne kodowane przestrzennie
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
WO2012061832A1 (en) 2010-11-05 2012-05-10 Illumina, Inc. Linking sequence reads using paired code tags
US9074251B2 (en) 2011-02-10 2015-07-07 Illumina, Inc. Linking sequence reads using paired code tags
CA2821559C (en) 2011-01-28 2017-01-31 Illumina, Inc. Oligonucleotide replacement for di-tagged and directional libraries
CN103443338B (zh) 2011-02-02 2017-09-22 华盛顿大学商业化中心 大规模平行邻接作图
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US20130017978A1 (en) 2011-07-11 2013-01-17 Finnzymes Oy Methods and transposon nucleic acids for generating a dna library
US9145623B2 (en) 2011-07-20 2015-09-29 Thermo Fisher Scientific Oy Transposon nucleic acids comprising a calibration sequence for DNA sequencing
WO2013117595A2 (en) 2012-02-07 2013-08-15 Illumina Cambridge Limited Targeted enrichment and amplification of nucleic acids on a support
NO2694769T3 (de) 2012-03-06 2018-03-03
CA2886974C (en) 2012-10-17 2021-06-29 Spatial Transcriptomics Ab Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
US9683230B2 (en) 2013-01-09 2017-06-20 Illumina Cambridge Limited Sample preparation on a solid support
ES2724824T3 (es) 2013-03-13 2019-09-16 Illumina Inc Métodos para la secuenciación de ácidos nucleicos
US9328382B2 (en) 2013-03-15 2016-05-03 Complete Genomics, Inc. Multiple tagging of individual long DNA fragments
CN105849275B (zh) 2013-06-25 2020-03-17 普罗格诺西斯生物科学公司 检测样品中生物靶标的空间分布的方法和系统
PT3021859T (pt) 2013-10-25 2018-03-09 Psioxus Therapeutics Ltd Adenovírus oncolíticos munidos de genes heterólogos
WO2015095226A2 (en) 2013-12-20 2015-06-25 Illumina, Inc. Preserving genomic connectivity information in fragmented genomic dna samples
WO2015106890A1 (en) * 2014-01-14 2015-07-23 Qiagen Gmbh Generation of tagged dna fragments
US20170009288A1 (en) 2014-02-03 2017-01-12 Thermo Fisher Scientific Baltics Uab Method for controlled dna fragmentation
US11136576B2 (en) 2014-02-03 2021-10-05 Thermo Fisher Scientific Baltics Uab Method for controlled DNA fragmentation
TWI682997B (zh) 2014-04-15 2020-01-21 美商伊路米納有限公司 用於改善插入序列傾向及增加ｄｎａ輸入耐受度之經修飾的轉位酶
SG11201609053YA (en) 2014-04-29 2016-11-29 Illumina Inc Multiplexed single cell gene expression analysis using template switch and tagmentation
WO2015179706A1 (en) 2014-05-23 2015-11-26 Fluidigm Corporation Haploidome determination by digitized transposons
US20150353989A1 (en) 2014-06-09 2015-12-10 Illumina Cambridge Limited Sample preparation for nucleic acid amplification
CA2952058A1 (en) 2014-06-13 2015-12-17 Illumina Cambridge Limited Methods and compositions for preparing sequencing libraries
US10017759B2 (en) 2014-06-26 2018-07-10 Illumina, Inc. Library preparation of tagged nucleic acid
SG11201610910QA (en) 2014-06-30 2017-01-27 Illumina Inc Methods and compositions using one-sided transposition
CN107109401B (zh) 2014-07-21 2021-02-19 亿明达股份有限公司 使用crispr-cas系统的多核苷酸富集
PT3207134T (pt) 2014-10-17 2019-09-17 Illumina Cambridge Ltd Transposição que preserva a contiguidade
KR102643955B1 (ko) 2014-10-17 2024-03-07 일루미나 케임브리지 리미티드 근접 보존 전위
DK3215618T3 (da) 2014-11-05 2019-10-14 Illumina Inc Transposasesammensætninger til reduktion af insertionsbias
CA2967351A1 (en) 2014-11-11 2016-05-19 Illumina, Inc. Polynucleotide amplification using crispr-cas systems
CN119410757A (zh) 2014-11-18 2025-02-11 莫德纳酶学有限公司 环状dna的扩增方法
ES2786652T3 (es) 2015-02-10 2020-10-13 Illumina Inc Métodos y composiciones para analizar componentes celulares
CA2982146A1 (en) 2015-04-10 2016-10-13 Spatial Transcriptomics Ab Spatially distinguished, multiplex nucleic acid analysis of biological specimens
US10844428B2 (en) 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
SG10201901482XA (en) 2015-04-30 2019-03-28 Psioxus Therapeutics Ltd Oncolytic adenovirus encoding a b7 protein
US11453875B2 (en) 2015-05-28 2022-09-27 Illumina Cambridge Limited Surface-based tagmentation
EP3303584B1 (de) 2015-05-29 2019-10-09 Epicentre Technologies Corporation Verfahren zur analyse von nukleinsäuren
CA2995305A1 (en) 2015-08-12 2017-02-16 Cemm Forschungszentrum Fur Molekulare Medizin Gmbh Methods for studying nucleic acids
ES2988429T3 (es) 2015-08-28 2024-11-20 Illumina Inc Análisis de secuencia de ácidos nucleicos de células individuales
SG11201805137XA (en) 2015-12-17 2018-07-30 Psioxus Therapeutics Ltd Virus encoding an anti-tcr-complex antibody or fragment
CN109477137B (zh) 2016-05-11 2023-05-30 伊鲁米那股份有限公司 使用argonaute系统的多核苷酸富集和扩增
WO2017199991A1 (ja) 2016-05-17 2017-11-23 国立研究開発法人 科学技術振興機構 環状ｄｎａの増幅方法
SG11201811504PA (en) 2016-07-22 2019-01-30 Univ Oregon Health & Science Single cell whole genome libraries and combinatorial indexing methods of making thereof
GB201713765D0 (en) 2017-08-28 2017-10-11 Psioxus Therapeutics Ltd Modified adenovirus
WO2018041827A1 (en) 2016-08-29 2018-03-08 Psioxus Therapeutics Limited Adenovirus armed with bispecific t cell engager (bite)
EP3565907B1 (de) 2017-01-06 2022-05-04 Editas Medicine, Inc. Verfahren zur beurteilung der nukleasespaltung
CA3050247A1 (en) 2017-01-18 2018-07-26 Illumina, Inc. Methods and systems for generation and error-correction of unique molecular index sets with heterogeneous molecular lengths
AU2018225503B2 (en) 2017-02-21 2024-07-18 Illumina Cambridge Limited Tagmentation using immobilized transposomes with linkers
KR102491725B1 (ko) * 2017-02-28 2023-01-27 오리시로 제노믹스 가부시키가이샤 환상 dna의 복제 또는 증폭 방법
CA3060369A1 (en) 2017-05-01 2018-11-08 Illumina, Inc. Optimal index sequences for multiplex massively parallel sequencing
SG11201910070PA (en) 2017-05-08 2019-11-28 Illumina Inc Universal short adapters for indexing of polynucleotide samples
US10914729B2 (en) 2017-05-22 2021-02-09 The Trustees Of Princeton University Methods for detecting protein binding sequences and tagging nucleic acids
SG10202108175RA (en) 2017-06-07 2021-09-29 Univ Oregon Health & Science Single cell whole genome libraries for methylation sequencing
CN111108219B (zh) 2017-08-01 2024-12-27 伊鲁米纳公司 使用的水凝胶珠和流动池的遗传物质的空间索引和文库制备
CA3073292A1 (en) 2017-08-21 2019-02-28 European Molecular Biology Laboratory Improved transposase polypeptide and uses thereof
US11447818B2 (en) 2017-09-15 2022-09-20 Illumina, Inc. Universal short adapters with variable length non-random unique molecular identifiers
DK3688157T3 (da) 2017-09-25 2022-07-04 Fred Hutchinson Cancer Center Høj effektiv in-situ målrettet genom profil
WO2019222688A1 (en) 2018-05-17 2019-11-21 Illumina, Inc. High-throughput single-cell sequencing with reduced amplification bias
KR102507415B1 (ko) 2018-06-04 2023-03-07 일루미나, 인코포레이티드 고속 대량 단일 세포 전사체 라이브러리 그리고 이의 제조 및 사용 방법
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
CN113767175A (zh) 2018-08-28 2021-12-07 10X基因组学股份有限公司 增加空间阵列分辨率
MX2021003772A (es) 2018-10-26 2021-05-27 Illumina Inc Modulacion de globulos de polimero para procesamiento de adn.
NL2022043B1 (en) 2018-11-21 2020-06-03 Akershus Univ Hf Tagmentation-Associated Multiplex PCR Enrichment Sequencing
WO2020112604A2 (en) 2018-11-30 2020-06-04 Illumina, Inc. Analysis of multiple analytes using a single assay
CA3119799A1 (en) 2018-12-04 2020-06-11 Catalent Pharma Solutions, Llc Vectors for protein manufacture
US20220025447A1 (en) 2018-12-10 2022-01-27 10X Genomics, Inc. Generating spatial arrays with gradients
US20220195507A1 (en) 2018-12-17 2022-06-23 Illumina, Inc. Methods and means for preparing a library for sequencing
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
EP3918088B1 (de) 2019-01-29 2024-03-13 MGI Tech Co., Ltd. Stlfr mit hoher abdeckung
WO2020169673A1 (en) 2019-02-19 2020-08-27 European Molecular Biology Laboratory Cell penetrating transposase
US20220033805A1 (en) 2019-03-01 2022-02-03 Sanjay Srivatsan High-throughput single-nuclei and single-cell libraries and methods of making and of using
WO2020243579A1 (en) 2019-05-30 2020-12-03 10X Genomics, Inc. Methods of detecting spatial heterogeneity of a biological sample
JP7603586B2 (ja) 2019-07-12 2024-12-20 イルミナ ケンブリッジ リミテッド 電気泳動を用いた核酸ライブラリの調製
WO2021023853A1 (en) 2019-08-08 2021-02-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Rna sequencing method for the analysis of b and t cell transcriptome in phenotypically defined b and t cell subsets
CN115176026A (zh) 2019-09-06 2022-10-11 分子医学研究中心责任有限公司 Rna寡核苷酸的测序方法
EP3918066A1 (de) 2019-10-25 2021-12-08 Illumina Cambridge Limited Verfahren zur erzeugung und sequenzierung von asymmetrischen adaptoren an den enden von polynukleotidtemplates mit haarnadelschleifen
WO2021092433A2 (en) 2019-11-08 2021-05-14 10X Genomics, Inc. Enhancing specificity of analyte binding
CN114008199A (zh) 2019-12-19 2022-02-01 伊路敏纳公司 高通量单细胞文库及其制备和使用方法
EP4424843A3 (de) 2019-12-23 2024-09-25 10X Genomics, Inc. Verfahren zur räumlichen analyse unter verwendung von rna-template-ligation
EP4081656A1 (de) 2019-12-23 2022-11-02 10X Genomics, Inc. Zusammensetzungen und verfahren zur verwendung von fixierten biologischen proben bei partitionsbasierten tests
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US12076701B2 (en) 2020-01-31 2024-09-03 10X Genomics, Inc. Capturing oligonucleotides in spatial transcriptomics
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US12129516B2 (en) 2020-02-07 2024-10-29 10X Genomics, Inc. Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
EP4139485B1 (de) 2020-04-22 2023-09-06 10X Genomics, Inc. Verfahren zur räumlichen analyse unter verwendung von gezieltem rna-abbau
EP4153776B1 (de) 2020-05-22 2025-03-05 10X Genomics, Inc. Räumliche analyse zur erkennung von sequenzvarianten
ES2989052T3 (es) 2020-05-22 2024-11-25 10X Genomics Inc Medición espacio-temporal simultánea de la expresión génica y la actividad celular
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
EP4163390A4 (de) 2020-06-03 2024-08-07 Tenk Genomics, Inc. Verfahren zur analyse einer zielnukleinsäure aus einer zelle
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
EP4421186A3 (de) 2020-06-08 2024-09-18 10X Genomics, Inc. Verfahren zur bestimmung eines chirurgischen randes und verfahren zur verwendung davon
WO2021252617A1 (en) 2020-06-09 2021-12-16 Illumina, Inc. Methods for increasing yield of sequencing libraries
EP4165207B1 (de) 2020-06-10 2024-09-25 10X Genomics, Inc. Verfahren zur bestimmung der position eines analyten in einer biologischen probe
AU2021294334A1 (en) 2020-06-25 2023-02-02 10X Genomics, Inc. Spatial analysis of DNA methylation
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
US12209280B1 (en) 2020-07-06 2025-01-28 10X Genomics, Inc. Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
WO2022031955A1 (en) 2020-08-06 2022-02-10 Illumina, Inc. Preparation of rna and dna sequencing libraries using bead-linked transposomes
KR20230051508A (ko) 2020-08-18 2023-04-18 일루미나, 인코포레이티드 핵산의 서열-특이적 표적화된 전위 및 선택과 분류
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
IL302728A (en) 2020-11-13 2023-07-01 Catamaran Bio Inc Genetically modified natural killer cells and methods of use thereof
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
US20220162288A1 (en) 2020-11-25 2022-05-26 Catamaran Bio, Inc. Cellular therapeutics engineered with signal modulators and methods of use thereof
WO2022140028A1 (en) 2020-12-21 2022-06-30 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
ES2993724T3 (en) 2021-01-29 2025-01-07 10X Genomics Inc Method for transposase mediated spatial tagging and analyzing genomic dna in a biological sample
FI4288562T3 (fi) 2021-02-04 2025-02-17 Illumina Inc Pitkien indeksoitujen ja linkitettyjen readien tuottaminen transposomiin sitoutuneille helmille
KR20230154078A (ko) 2021-03-09 2023-11-07 일루미나, 인코포레이티드 CAS-gRNA 리보핵단백질을 사용한 게놈 라이브러리 제작 및 표적화된 후성적 검정
KR20230161979A (ko) 2021-03-29 2023-11-28 일루미나, 인코포레이티드 개선된 라이브러리 제조 방법
EP4314283A1 (de) 2021-03-31 2024-02-07 Illumina, Inc. Verfahren zur herstellung von direktionalen tagmentationssequenzierungsbibliotheken mit transposonbasierter technologie mit eindeutigen molekularen identifikatoren zur fehlerkorrektur
JP2024512463A (ja) 2021-03-31 2024-03-19 イルミナ インコーポレイティッド 増幅されたライブラリからの望ましくない断片の選択的枯渇のためのブロッキングオリゴヌクレオチド
EP4305196B1 (de) 2021-04-14 2025-04-02 10X Genomics, Inc. Verfahren zur messung der fehllokalisierung eines analyten
EP4347879B1 (de) 2021-06-03 2025-02-19 10X Genomics, Inc. Verfahren, zusammensetzungen, kits und systeme zur verbesserung der analyterfassung zur räumlichen analyse
CN117693595A (zh) 2021-06-07 2024-03-12 中国海洋大学 分析样品组学信息的产品和方法
EP4380967A1 (de) 2021-08-04 2024-06-12 The Regents of the University of Colorado, a body corporate Lat-aktivierende chimäre antigenrezeptor-t-zellen und verfahren zur verwendung davon
CA3223731A1 (en) 2021-08-11 2023-02-16 Illumina, Inc. Detection of analytes using targeted epigenetic assays, proximity-induced tagmentation, strand invasion, restriction, or ligation
WO2023034489A1 (en) 2021-09-01 2023-03-09 10X Genomics, Inc. Methods, compositions, and kits for blocking a capture probe on a spatial array
WO2023102118A2 (en) 2021-12-01 2023-06-08 10X Genomics, Inc. Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
WO2023172514A1 (en) 2022-03-07 2023-09-14 Catamaran Bio, Inc. Engineered immune cell therapeutics targeted to her2 and methods of use thereof
WO2023225519A1 (en) 2022-05-17 2023-11-23 10X Genomics, Inc. Modified transposons, compositions and uses thereof
CN119497755A (zh) 2022-06-30 2025-02-21 卡帕生物系统公司 使用古细菌组蛋白样蛋白针对片段化并加标签测序文库插入片段大小进行控制
WO2025049905A1 (en) 2023-09-01 2025-03-06 Gennao Bio, Inc. Dnase co-expression in host cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137829A (en) * 1987-10-05 1992-08-11 Washington University DNA transposon TN5SEQ1
US5212080A (en) * 1987-10-05 1993-05-18 Washington University Method of DNA sequencing using DNA transposon Tn5seql
NL8801805A (nl) * 1988-07-15 1990-02-01 Rijksuniversiteit Dna sequencing methode en daarvoor bruikbare primer.
AU8657691A (en) * 1990-08-24 1992-03-17 United States of America, as represented by the Secretary, U.S. Department of Commerce, The In vitro retroviral integration assay
US5227288A (en) * 1990-10-01 1993-07-13 Blattner Frederick R DNA sequencing vector with reversible insert
US5677170A (en) * 1994-03-02 1997-10-14 The Johns Hopkins University In vitro transposition of artificial transposons

Also Published As

Publication number Publication date
EP0698124B1 (de) 2000-05-24
US5968785A (en) 1999-10-19
US5843772A (en) 1998-12-01
JPH08510388A (ja) 1996-11-05
CA2161767A1 (en) 1995-09-08
US5677170A (en) 1997-10-14
WO1995023875A1 (en) 1995-09-08
AU1973995A (en) 1995-09-18
JP3832851B2 (ja) 2006-10-11
DE69517105T2 (de) 2000-11-16
US5728551A (en) 1998-03-17
EP0698124A1 (de) 1996-02-28
AU682588B2 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
DE69517105D1 (de) In vitro transposition von artifiziellen transposons mit stumpfen enden
FI960888L (fi) Protokadheriiniproteiineja ja niiden käyttö
FI963560A0 (fi) Sidontamääritys, jossa käytetään häntäryhmiä sisältäviä sidonta-aineita
DE69627716D1 (de) Perfluorelastomer-zusammensetzung mit erhöhter vulkanisationseigenschaften
FI971955A0 (fi) Dopamineeristen solujen indusointi in vitro
FI964912A (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
FI964911A0 (fi) Parannuksia elintarviketuotteiden valmistamiseen ja siihen liittyen
DE59503964D1 (de) Disazofarbstoffe
FI955973A0 (fi) Keinotekoinen lasikuituvilla
EP0704458A3 (de) Antikörper gegen Typ-IV-Kollagen und dessen Verwendung
DE59406928D1 (de) Neue Azofarbstoffe, deren Herstellung und Verwendung
DE69503641D1 (de) Sulfatagglomeration
KR960002831U (ko) 기 게양대
KR950009390U (ko) 승 · 하강식 등기구를 갖춘 전주
KR950031840U (ko) 인공어초
GB9620329D0 (en) Sign with/without illumination
ATA98493A (de) Dreieckförmiges sonnensegel
KR950032025U (ko) 자연물이 내장된 테이블
KR950009385U (ko) 수동 자가발전장치가 부설된 손전등
GB9408813D0 (en) Combined marking instrument and light
KR960026771U (ko) 화음을 내게한 팽이와 팽이채
KR960018134U (ko) 장식구를 갖는 탕수혼합수전
KR960016149U (ko) 색연필 케이스
KR950032471U (ko) 2종류의 날이 부착된 공작용 가위
BR7400189U (pt) Prancheta manual com estojo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee